My last post had me thinking about ways to mess with the FDA after our first approval. Let it be known that leronlimab would be available for long haulers only under FDA compassionate use. The only thing necessary is to send blood samples on a regular basis for testing cytokine levels and immune cell levels. That could bolster the case for leronlimab as an immunomodulator.

Of course the FDA would be swamped with requests after word became widespread about leronlimab's effectiveness. Then the FDA has a dilemma on it's hands. Try to deal with the huge number of requests or refuse to process them anymore and have tens of thousands of angry people on it's hands. They wouldn't have the excuse this time to shut down requests to funnel people into a trial. They may even plead with Cytodyn to do a phase 3 trial.